tiprankstipranks
Trending News
More News >
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market

NewAmsterdam Pharma Company (NAMS) Revenue

Compare
247 Followers

NewAmsterdam Pharma Company Revenue

NewAmsterdam Pharma Company had a revenue of 32.00K in the quarter ending Dec 31, 2025, with -90.80%. This bring the company's revenue in the last twelve months to 22.50M, Increased -36.15%. In the fiscal year ending Dec 31, 2025, NewAmsterdam Pharma Company had annual revenue of 22.50M with -50.61% growth.
Revenue (ttm)
22.50M
Revenue Growth
P/S Ratio
155.63
Revenue/Employee
$330,926
Employees
68
Market Cap
$3.50B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
22.50M-23.06M-50.61%
Dec 31, 2024
45.56M31.47M+223.37%
Dec 31, 2023
14.09M-88.60M-86.28%
Mar 31, 2023
102.69M+∞%
Dec 31, 2021
Dec 31, 2020